{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ORKA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":10.265,"timestamp":1746033051480,"preClose":10.45,"halted":0,"volume":56346,"delay":0,"floatShares":24529621,"shares":37440510,"eps":-4.225857,"marketStatus":"Trading","change":-0.185,"latestTime":"04-30 13:13:10 EDT","open":10.65,"high":10.65,"low":9.9,"amount":571252.989876,"amplitude":0.07177,"askPrice":10.29,"askSize":431,"bidPrice":10.25,"bidSize":72,"shortable":3,"etf":0,"ttmEps":-4.225857,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":10.45,"preHourTrading":{"tag":"盘前","latestPrice":9.85,"preClose":10.45,"latestTime":"08:41 EDT","volume":562,"amount":5745.659828,"timestamp":1746016864981},"postHourTrading":{"tag":"盘后","latestPrice":10.45,"preClose":10.45,"latestTime":"16:05 EDT","volume":899,"amount":9394.55,"timestamp":1745957105743},"volumeRatio":0.544376,"impliedVol":0.7944,"impliedVolPercentile":0.6222},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":24529621,"roa":"--","roe":"--","lyrEps":-3.873702,"volumeRatio":0.544376,"shares":37440510,"dividePrice":0,"high":10.65,"amplitude":0.07177,"preClose":10.45,"low":9.9,"week52Low":5.485,"pbRate":"1.01","week52High":53.88,"institutionHeld":0.0223,"latestPrice":10.265,"committee":-0.713718,"eps":-4.225857,"divideRate":0,"volume":56346,"delay":0,"ttmEps":-4.225857,"open":10.65,"prevYearClose":19.39,"prevWeekClose":10.09,"prevMonthClose":10.26,"prevQuarterClose":10.26,"fiveDayClose":10.58,"twentyDayClose":9.56,"sixtyDayClose":13.7},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ORKA\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORKA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531781612","title":"Oruka Therapeutics to Present at Bank of America Securities 2025 Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2531781612","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531781612?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., April 29, 2025  -- Oruka Therapeutics, Inc.  , a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13th, 2025, at 3:55 PM PT.Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oruka-therapeutics-present-bank-america-110000866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2129689431.USD","IE00BZ1G4Q59.USD","LU0310800965.SGD","LU0149725797.USD","LU1363072403.SGD","LU1496350171.SGD","IE00BFXG1179.USD","LU0106831901.USD","BK4139","LU2129689605.HKD","IE0002270589.USD","LU0256863902.USD","BK4207","LU0098860793.USD","LU0128525689.USD","LU1201861249.SGD","BK4581","LU0070302665.USD","LU1201861165.SGD","LU0321505439.SGD","ORKA","BK4553","LU0320765646.SGD","LU1894683348.USD","LENZ","IE00BLSP4452.SGD","LU0306806265.USD","LU0314106906.USD","IE00B7SZLL34.SGD","LU0320765489.SGD","LU0477156797.USD","BAC","LU1791807156.HKD","LU1880398554.USD","BK4585","LU0130102774.USD","LU2129689514.USD","BK4504","LU0130103400.USD","LU0648001328.SGD","IE00B19Z3581.USD","LU0417517546.SGD","LU0052756011.USD","LU0321505868.SGD","BK4534","LU0971096721.USD","LU1880398471.USD","LU0683600562.USD","LU0868494617.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2529721198","title":"Oruka Therapeutics Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2529721198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529721198?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:17","pubTimestamp":1745234225,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc  expected to post a loss of52cents a share - Earnings Preview Oruka Therapeutics Inc ORKA.OQ ORKA.O is expected to report resultson April 23 (estimated) for the period ending Ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nL8N3QZ0FP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA"],"gpt_icon":0},{"id":"2517410724","title":"We're Not Very Worried About Oruka Therapeutics' (NASDAQ:ORKA) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410724","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517410724?lang=en_us&edition=fundamental","pubTime":"2025-03-08 21:49","pubTimestamp":1741441796,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?So should Oruka Therapeutics  shareholders be worried about its cash burn?In this article, we define cash burn as its annual  free cash flow, which is the amount of money a company spends each year to fund its growth. Let's start with an examination of the business' cash, relative to its cash burn.Check out our latest analysis for Oruka Therapeutics. When Might Oruka Therapeutics Run Out Of Money?If you would prefer to check out another company with better fundamentals, then do not miss this free list of interesting companies, that have HIGH return on equity and low debt or this list of stocks which are all forecast to grow.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/were-not-very-worried-oruka-134956436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BKPKM429.USD","BK4139","MNQmain","SQQQ","BK4112",".IXIC","QID","TSYW.SI","USJW.SI","BK4588","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","LU2095319765.USD","BK4585","NVIW.SI","LU2210149790.SGD","ORKA","PSQ","QLD","TQQQ","LU2210150020.SGD","USAW.SI","IE00BGHQF748.EUR","NQmain"],"gpt_icon":1},{"id":"2517041562","title":"Oruka Therapeutics at Risk: Navigating Licensing Challenges and Partner Reliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2517041562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517041562?lang=en_us&edition=fundamental","pubTime":"2025-03-08 14:01","pubTimestamp":1741413661,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics, Inc. (ORKA) has disclosed a new risk, in the Trade Secrets category. Oruka Therapeutics, Inc. faces significant business risks ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oruka-therapeutics-at-risk-navigating-licensing-challenges-and-partner-reliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oruka-therapeutics-at-risk-navigating-licensing-challenges-and-partner-reliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","ORKA"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12},{"date":"2024-08-29","symbol":"ORKA","amount":1.613,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-26","defaultRemindTime":1724938200000,"name":"方舟生物医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-08-26","currency":"USD","dateTimestamp":1724904000000,"payDate":"2024-08-28"},{"market":"US","date":"2024-08-01","symbol":"ORKA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-04-25","symbol":"ORKA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-02-01","symbol":"ORKA","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706763600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2025-04-29","current":-4.214018,"percent":0.485714,"low":-5.124049,"twenty":-4.767415,"median":-4.209919,"eighty":-3.508949,"high":-2.779284,"avg":-4.12821,"sd":0.670929,"marketCap":384888442},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355},{"date":"2025-04-29","current":-4.214018,"twenty":-4.767415,"median":-4.209919,"eighty":-3.508949,"marketCap":384888442}],"updateTime":1746024280541}}}